Overview

Atrasentan Spermatogenesis and Testicular Function

Status:
Completed
Trial end date:
2018-07-16
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the effects of Atrasentan on sperm production and testicular function in male subjects with Type 1 or 2 Diabetes and Nephropathy. This study included 2 periods: a Treatment Period (up to 26 weeks) followed by an Observational Period (up to an additional 52 weeks).
Phase:
Phase 2
Details
Lead Sponsor:
AbbVie
Treatments:
Atrasentan